References
- Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med. 2005;118 Suppl 12B (Suppl 12B):131–135.
- Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14(3):567–571.
- Rosano GM, Vitale C, Marazzi G, et al. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10(sup1):19–24.
- de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Maturitas. 2013;74(4):391–392.
- de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–155.
- The NHTPSAP. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24:728–753.
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333.
- Namnoum AB, Hickman TN, Goodman SB, et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64(5):898–902.
- Redwine DB. Endometriosis persisting after castration: clinical characteristics and results of surgical management. Obstet Gynecol. 1994;83(3):405–413.
- Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
- Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116:223–236.
- Rattanachaiyanont M, Tanmahasamut P, Angsuwatthana S, et al. Hormonal replacement therapy in surgical menopause with underlying endometriosis. J Med Assoc Thai. 2003;86(8):702–707.
- Gemmell LC, Webster KE, Kirtley S, et al. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23(4):481–500.
- Cheewadhanaraks S, Choksuchat C, Wattanakumtornkul S. Estrogen plus progestin versus estrogen after definitive surgery for endometriosis: a study of pain recurrence. J Med Assoc Thai. 2013;96(8):881–887.
- Fedele L, Bianchi S, Raffaelli R, et al. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas. 1999;32(3):189–193.
- Matorras R, Elorriaga MA, Pijoan JI, et al. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002;77(2):303–308.
- Taylor HS, Pal L, Seli E. Menopausal transition and menopausal hormone therapy. In: Taylor HS, Pal L, Seli E, editors. Speroff's clinical gynecologic endocrinology and infertility. 9th ed. Philadelphia (PA): Wolters Kluwer; 2020. p. 581–751.
- Kadri Hassan AH, Al-Fozan Hm S, Hajeer A. Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev. 2009;(1):CD005997.
- Sundar SS, Gornall RJ, Kerr-Wilson R, et al. A case report of recurrent endometriosis following tibolone hormone replacement therapy. J Obstet Gynaecol. 2007;27(4):433–434.
- Burney RO. The genetics and biochemistry of endometriosis. Curr Opin Obstet Gynecol. 2013;25(4):280–286.
- Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75(6):1023–1028.